Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. XORTX Therapeutics Inc (XRTX)

  7. XORTX Therapeutics Inc (XRTX) Financials

XRTX

XORTX Therapeutics Inc
0.4851
0.005 (1.04%)
Upgrade to Real-Time

XORTX Therapeutics Inc. (XRTX) Fundamentals
XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.
SHARE INFORMATION
Market Cap$ 6,908,489
Shares Outstanding17,989,687
Float13,823,603
Percent Float96.07%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions8
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months367
Institutional Holdings Percent10.7%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 2.29
52 Week Low$ 0.43
52 Week High Change$ -72.57
21 Day Moving Average$ 0.5382
21 Day Extended Moving Average$ 0.53439
50 Day Moving Average$ 0.6111
50 Day Extended Moving Average$ 0.608413
200 Day Moving Average$ 1.015
200 Day Extended Moving Average$ 0.994138
10 Day Average Volume66,089
20 Day Average Volume88,514
30 Day Average Volume85,357
50 Day Average Volume1,102,828
Alpha0.019637
Beta0.8600
Standard Deviation0.367293
R20.018595
7 Day Price Change$ -0.0199
7 Day Percent Change-3.98%
21 Day Price Change$ -0.1099
21 Day Percent Change-18.63%
30 Day Price Change$ -0.0751
30 Day Percent Change-13.53%
Month to Date Price Change$ -0.1086
Month to Date Percent Change-18.45%
Quarter to Date Price Change$ -0.3279
Quarter to Date Percent Change-40.58%
180 Day Price Change$ -0.7299
180 Day Percent Change-60.32%
200 Day Price Change$ -0.9199
200 Day Percent Change-65.71%
Year to Date Price Change$ -0.3279
Year to Date Percent Change-40.58%

XORTX Therapeutics Inc. (XRTX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.90
Total Debt To Equity0.00
Int Coverage1,526.60
Current Ratio6.70
Leverage Ratio1.40
Quick Ratio6.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio1.30
Enterprise Value$ -1,803,265
Price to Sales0.00
Price to Free Cash-1.40
PE High Last 5 Years-5.00
Price To Book0.90
Price To Cash Flow386.40
PE Low Last 5 Years-18.00
Price to Tangible Book0.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets22.77
Return on Equity74.41
Return on Capital75.21

XORTX Therapeutics Inc. (XRTX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorSmythe LLP
CEOAllen Warren Davidoff
Emplyoees3
Last AuditUQ
CIK0001729214
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address421 - 7th Avenue SW
Suite 4000
Calgary, AB T2P 4K9
Websitehttps://www.xortx.com
Facsimile+1 403 260-3501
Telephone+1 403 607-2621
Email-


Your Recent History
NASDAQ
XRTX
XORTX Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.